- Home
- KTF vs HUMA Comparison
KTF vs HUMA Comparison
Compare KTF & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTF
- HUMA
- Stock Information
- Founded
- KTF 1988
- HUMA 2004
- Country
- KTF United States
- HUMA United States
- Employees
- KTF N/A
- HUMA N/A
- Industry
- KTF Finance Companies
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- KTF Finance
- HUMA Health Care
- Exchange
- KTF Nasdaq
- HUMA Nasdaq
- Market Cap
- KTF 337.7M
- HUMA 250.2M
- IPO Year
- KTF N/A
- HUMA N/A
- Fundamental
- Price
- KTF $8.79
- HUMA $1.51
- Analyst Decision
- KTF
- HUMA Strong Buy
- Analyst Count
- KTF 0
- HUMA 8
- Target Price
- KTF N/A
- HUMA $10.88
- AVG Volume (30 Days)
- KTF 103.3K
- HUMA 5.9M
- Earning Date
- KTF 01-01-0001
- HUMA 08-11-2025
- Dividend Yield
- KTF 3.54%
- HUMA N/A
- EPS Growth
- KTF N/A
- HUMA N/A
- EPS
- KTF 0.39
- HUMA N/A
- Revenue
- KTF N/A
- HUMA $818,000.00
- Revenue This Year
- KTF N/A
- HUMA N/A
- Revenue Next Year
- KTF N/A
- HUMA $949.92
- P/E Ratio
- KTF $23.10
- HUMA N/A
- Revenue Growth
- KTF N/A
- HUMA N/A
- 52 Week Low
- KTF $7.40
- HUMA $1.15
- 52 Week High
- KTF $9.12
- HUMA $6.77
- Technical
- Relative Strength Index (RSI)
- KTF 63.49
- HUMA 36.87
- Support Level
- KTF $8.63
- HUMA $1.43
- Resistance Level
- KTF $8.74
- HUMA $1.67
- Average True Range (ATR)
- KTF 0.06
- HUMA 0.15
- MACD
- KTF 0.02
- HUMA -0.01
- Stochastic Oscillator
- KTF 96.12
- HUMA 23.32
About KTF DWS Municipal Income Trust
DWS Municipal Income Trust is a closed-ended fixed income mutual fund launched and managed by Deutsche Investment Management Americas, Inc. The company invests in the fixed income markets of the United States. The fund invests in investment-grade tax-exempt municipal securities which are exempt from federal income tax. The fund benchmarks the performance of its portfolio against the Barclays Municipal Bond Index. The Fund invests in various states, such as Texas, Florida, Pennsylvania, Illinois, and California.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.